Table 4 Univariate analysis of different characteristics and progression-free survival of LVSI+ population
Mean PFS | SE | 95% CI of PFS | P | ||
|---|---|---|---|---|---|
Lower limit | Upper limit | ||||
Age | |||||
< 45 years | 77.564 | 3.025 | 71.635 | 83.493 | .997 |
≥ 45 years | 72.486 | 1.966 | 68.633 | 76.339 | |
Tumor size | |||||
< 2 cm | 76.985 | 2.594 | 71.901 | 82.068 | .656 |
≥ 2 cm | 72.368 | 2.048 | 68.354 | 76.381 | |
SCC (ng/ml) | |||||
< 1.5 | 75.167 | 1.985 | 71.276 | 79.059 | .377 |
≥ 1.5 | 76.451 | 2.560 | 71.434 | 81.468 | |
Surgical approach | |||||
Laparotomy | – | – | – | – | – |
Laparoscopic | 78.345 | 2.422 | 73.597 | 83.092 | .418 |
Robotic | 65.120 | 1.842 | 61.510 | 68.730 | |
FIGO stage | |||||
IB1 | 80.089 | 1.665 | 76.825 | 83.353 | .072 |
IIA1 | 71.688 | 3.877 | 64.090 | 79.287 | |
Depth of stromal invasion | |||||
Superficial 1/3 | 66.870 | 3.821 | 59.381 | 74.359 | .153 |
Middle 1/3 | 80.152 | 1.985 | 76.262 | 84.042 | |
Deep 1/3 | 69.778 | 2.181 | 65.504 | 74.052 | |
Lymph node invasion | |||||
Absent | 79.135 | 1.691 | 75.820 | 82.450 | .061 |
Present | 62.028 | 5.345 | 51.551 | 72.505 | |
Histopathologic grades | |||||
G1 | 77.000 | 3.795 | 69.562 | 84.438 | .001 |
G2 | 80.354 | 1.502 | 77.410 | 83.299 | |
G3 | 49.667 | 7.237 | 35.481 | 63.852 | |
Adjuvant therapy | |||||
Chemotherapy | 71.020 | 4.136 | 62.913 | 79.127 | .036 |
Chemoradiotherapy | 80.027 | 1.681 | 76.732 | 83.323 | |